GNOM Stock Price Prediction 2027
Global X Genomics & Biotechnology ETF
AI-powered price predictions based on fundamental analysis and growth projections
GNOM Price Forecast 2027: Our AI models project that GNOM stock will rise to approximately $73.10 by 2027. This represents a potential 15.0% growth from the current trading price of $63.57. The overall market sentiment for GNOM is currently bullish, based on a combination of proprietary technical signals and fundamental analysis.
About This ETF: GNOM is the Global X Genomics & Biotechnology ETF focused on genomics. Because an ETF tracks a basket of holdings rather than a single company, our 2027 forecast for GNOM is driven primarily by price trend, momentum and volatility of the fund itself instead of company-level earnings estimates. Over the past 52 weeks the fund has traded between $62.22 and $63.57, and currently sits in the upper part of that range (100% of the way up). Investors typically use GNOM to get diversified exposure to the genomics theme in a single position, so the prediction above is best read as a view on the whole basket, not any individual constituent.
Technical Outlook: The stock is technically in a downtrend phase. The Relative Strength Index (RSI) is currently 50.0, which suggests the stock is trading in a neutral range. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2027 predicted target.
- Recent pattern: Doji - Indecision pattern
- Price near support at $61.97
Volume Trend: Slight_Accumulation
Selling Pressure Present - Distribution pattern observed
Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $64.33 | +1.2% |
| 90 Days | $65.95 | +3.7% |
| 6 Months | $68.34 | +7.5% |
| 1 Year | $73.10 | +15.0% |
More GNOM Analysis
Scenario Analysis (1-Year Outlook)
Best case scenario if strong fundamentals and market conditions align
Expected scenario based on current growth trajectory
Downside scenario if market headwinds or disappointing results
Technical Indicators
Frequently Asked Questions
What is the GNOM stock price prediction for 2027?
Based on our AI analysis, GNOM is predicted to reach $73.10 by 2027, representing a potential 15.0% increase from the current price of $63.57.
Is GNOM stock a good buy right now?
Our analysis suggests GNOM is a "BUY" based on current technical and fundamental indicators. With a projected 15.0% upside, investors should consider their risk tolerance and investment horizon.
What is GNOM 52-week high and low?
GNOM has a 52-week high of $63.57 and a 52-week low of $62.22. The stock is currently trading 0.0% below its 52-week high.
What is the technical analysis for GNOM?
GNOM is currently in a downtrend trend. The RSI of 50.0 indicates the stock is trading in neutral territory. Traders should monitor support and resistance levels for potential entry points.
What does the GNOM ETF track?
GNOM is the Global X Genomics & Biotechnology ETF, giving diversified exposure to genomics. Unlike a single stock, its price reflects a basket of holdings, so our 2027 forecast is based on the fund's own price trend, momentum and volatility rather than one company's earnings.